More
    Guided Solutions - Connecting Talent With Innovation/div>

    ClearPoint Neuro announces investment of up to $110M by Oberland Capital

    ClearPoint Neuro, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it has entered...

    OrganOx announces second private placement closing

    OrganOx Ltd., a leading organ medical technology company, completed a second closing of its private placement with investments from Intuitive Ventures, Terumo Ventures, and...

    InBrain awarded €4m to accelerate development of its BCI platform

    InBrain Neuroelectronics has won a €4m ($4.5m) grant from the Spanish Ministry of Industry and Tourism to develop its brain-computer interface (BCI) platform technology. InBrain’s...

    Aktiia raises $42M for blood pressure monitoring tech, rebrands to Hilo

    Aktiia announced today that it raised an oversubscribed $42 million Series B funding round and introduced its new “Hilo” brand identity. Earlybird Health and...

    Voom Medical Devices announces $30M debt and equity financing

    Voom Medical Devices, a leader in minimally invasive orthopedic solutions, today announced the successful closing of a $30 million capital raise through a combination...

    Spark Biomedical closes $15M Series A for wearable neurostim

    Spark Biomedical closed a $15 million Series A round to support its bioelectronic neurostimulation technologies. Wave Ventures led the financing round, which also received support...

    Chipiron raises $17M to support miniaturised MRI scanner

    Chipiron raised $17 million in a funding round to complete the development of its miniaturized MRI scanner. The French company says the funds enable...

    Field Medical raises $40m Series A for pulsed field ablation tech

    Field Medical closed a Series A financing round worth $40 million to support its pulsed field ablation (PFA) technology. Cardiff-by-the-Sea, California–based Field Medical was founded...

    Biolinq closes $100m Series C funding round for biosensor platform

    Biolinq closed a $100 million Series C funding round to advance its biosensor platform. “This financing will bolster Biolinq’s commercial readiness efforts while we pursue...

    Latest articles